Company News
ImmunityBio Shares Rise 3% After FDA Response
ImmunityBio shares jumped 3% on Monday after filing a detailed response to FDA promotional compliance concerns raised on March 13, 2026.
The company clarified the TV ad was never aired, removed a podc
